Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

CSTL

CASTLE BIOSCIENCES INC

Services-Medical Laboratories · SIC 8071CIK 1447362Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$344.0M
Net Income FY2025
$(24.0M)
EPS (Basic, as reported)
$-0.83
Net Margin FY2025
-7.0%
ROE FY2025
-5.1%
Total Equity
$471.0M
Shares Out
31M
Business description

CASTLE BIOSCIENCES INC — Services-Medical Laboratories. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2018–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 23 → 344 +47.2% CAGR
Revenue23526394137220332344
Cost of revenue(5)(7)(10)(16)(32)(45)(60)(71)
Gross profit174553—————
Research & development(5)(7)(13)(30)(45)(54)(52)(52)
Selling, general & administrative(16)(30)(48)(87)(143)(180)(200)(229)
Total operating expenses(21)(37)——————
Operating income(4)7(7)(40)(73)(68)9(43)
Interest expense(2)(5)(3)000(1)0
Interest & investment income00004111312
Other income (expense), net0(3)0——000
Income tax expense000(9)(2)0(3)(5)
Net income(6)5(10)(31)(67)(57)18(24)
EPS — basic($5.33)$0.35($0.54)($1.24)($2.58)($2.14)$0.66($0.83)
EPS — diluted($5.33)($0.21)($0.54)($1.24)($2.58)($2.14)$0.62($0.83)
Shares outstanding — basic (M)29192526272829
Shares outstanding — diluted (M)29192526272929
  • ⚑ Weighted-average shares changed ×4.50 between FY2018 and FY2019 — likely a stock split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×2.11 between FY2019 and FY2020 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.